欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Endothelin Receptor

Endothelin Receptor

货号 产品名 CAS号 信息
CSN13675 Zibotentan 186497-07-4 Zibotentan is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
CSN12014 Sulfisoxazole 127-69-5 Sulfisoxazole is an antagonist of endothelin receptor that can be used as a sulfonamide antibacterial agent.
CSN11008 Sodium Ferulate 24276-84-4 Sodium ferulate is the sodium salt of ferulic acid which is used for the treatment of cardiovascular disease.
CSN12974 Sitaxsentan Sodium 210421-74-2 Sitaxsentan sodium has selectory antagonism of endothelin A (ETA) receptor with the IC50 and Ki value of 1.4 nM and 0.43 nM respectively.
CSN12975 Sitaxsentan 184036-34-8 Sitaxsentan is a selective endothelin A (ETA) receptor antagonist.
CSN17902 Ro 46-2005 150725-87-4 Ro 46-2005 is an antagonist of endothelin receptor.
CSN25744 IRL-2500 169545-27-1 IRL-2500 is a potent endothelin receptor antagonist with IC50 values of 1.3 and 94 nM for ETB and ETA receptors respectively.
CSN23533 Darusentan 171714-84-4 Darusentan is an antagonist of endothelin ETA receptor and it can be used to treat congestive heart failure and hypertension.
CSN19760 Clazosentan 180384-56-9 Clazosentan is a potent endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury.
CSN17348 BQ-788 Sodium 156161-89-6 BQ-788 sodium salt is a potent, selective ETB receptor antagonist with IC50 of 1.2 nM for inhibition of ET-1 binding to human Girardi heart cells, poorly inhibiting the binding to ETA receptors in human neuroblastoma cell line SK-N-MC cells with IC50 of 1300 nM.
CSN18010 BQ-788 173326-37-9 BQ-788 is a potent and selective endothelin receptor subtype B (ETB) antagonist with IC50 of 1.2 nM (inhibits 125I-labeled endothelin 1 (ET-1) binding to ETB receptors on human Girardi heart cells).
CSN17753 BQ-123 136553-81-6 BQ-123 is a specific antagonist of endothelin A receptor (ETA) and the IC50 is 7.3 nM.
CSN10480 Bosentan 147536-97-8 Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.
CSN12872 Avosentan 290815-26-8 Avosentan is a potent, selective endothelin receptor (ETA receptor) antagonist.
CSN18015 Atrasentan 173937-91-2 Atrasentan is an endothelin receptor antagonist (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
CSN13753 Atrasentan HCl 195733-43-8 Atrasentan HCl is an endothelin receptor antagonist (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
CSN10496 Ambrisentan   177036-94-1 Ambrisentan is an oral, once-daily endothelin receptor antagonist that is selective for the endothelin type A receptor (IC50s = 0.251, 0.316, 0.398, 251, and 630 nM for rat preparations of heart, bladder, kidney, lung, and cerebral cortex, respectively).
CSN25741 A 127722 195704-72-4 A 127722 is a potent ETA endothelin receptor antagonist with IC50 values of 0.11 nM and 98 nM for human ETA and ETB receptors, respectively.
<< PREV 1 NEXT >>
联系
我们